MediFormatica’s Post

Go-Live Alert! 🚀 We’re thrilled to announce the successful go-live at The Toledo Clinic in Toledo, OH! 🎉Our team has rolled out a suite of solutions designed to enhance patient care and streamline operations. Here’s what we’ve achieved: 🔗 Key Solutions Delivered: - CareFlow RIS & Patient Engagement Workflows: Facilitating seamless communication and improved patient care. - AbbaDox Breast Health: Leveraging AI-powered data capture for greater accuracy in diagnostics. - Integrated Ecosystem: Interfaces with ECW, OncoEMR, and Infinx for a fully connected system. - Task Management: Streamlining operations for better efficiency. - Data Migration: Safeguarding essential patient records from the previous vendor. - Lung Screening Capabilities: Enhancing early detection for better patient outcomes. A huge shoutout to our dedicated team and partners who made this milestone possible. 💪 #Radiology #HealthcareIT #Interoperability #PatientCare #Toledo

🌟 4 Reasons Why with LungVision®, It's Not, "Can I Afford It?" but, "Can I Afford Not To?" 🌟 In today's healthcare environment, making the right investment in technology can be a game-changer for both clinicians and patients. LungVision® by Body Vision Medical is a prime example of such transformative technology. Here are four compelling reasons why LungVision® AI-driven image guidance is a critical investment you can't afford to overlook: Superior Clinical Outcomes 🩺 LungVision's real-time imaging and advanced navigation capabilities dramatically improves clinicians' ability to definitely diagnose (or rule out) lung cancer, reducing diagnosis to treatment times, improving survival rates, and elevating quality of life for patients. Radiation Reduction 🌟 LungVision® reduces the need for excessive radiation during procedures, protecting both patients and healthcare providers. Flexibility 🔄 Whether you're working with reusable bronchoscopes or robotic bronchoscopy platforms, LungVision® integrates seamlessly with existing workflows and equipment, allowing for a more precise, streamlined (read shorter) lung nodule biopsy procedure. Cost Savings 💰 Beyond a lower upfront investment, LungVision® delivers significant cost savings over time by lowering or eliminating cost-per-case as well as improving diagnostic accuracy and reducing complications. Investing in LungVision® by Body Vision Medical means prioritizing excellence in patient care, operational efficiency, and long-term financial health. It's not just about affording the technology—it's about recognizing the invaluable benefits it brings to your practice and your patients. 🔗 Learn how institutions like Cleveland Clinic, North Memorial Health Hospital, and Jefferson Einstein Montgomery Hospital revolutionized their lung nodule programs with LungVision®: https://lnkd.in/dV7dDtx #HealthcareInnovation #LungVision #BodyVisionMedical #ClinicalOutcomes #RadiationReduction #MedicalTechnology #CostSavings #HealthcareExcellence #AdvancedBronchoscopy #LungCancer

💬 Patient voices driving innovation At Naitive, our mission is to enable the early detection and effective management of chronic conditions like osteoporosis, helping people live healthier, longer lives. We are developing AI-enabled technologies that leverage existing data to identify osteoporosis earlier and close the care gaps in today's healthcare systems. Our bone health platform, OsteoSight™, automatically screens X-rays taken for other reasons to detect hidden signs of osteoporosis, enabling clinicians to intervene before fractures occur. This innovation is only possible with input from those who need it most. That's why we are honored to collaborate with the Royal Osteoporosis Society, with whom we have established a steering committee. This committee and its patient volunteers provide valuable input and feedback on our development through a series of regular meetings. They offer essential insights, particularly on how we communicate findings and the real-world impact of our technology. Two of the patient volunteers recently shared with us their thoughts on the project: 👉 Irene Baker, a Patient Volunteer, noted, "Osteoporosis is often diagnosed too late. The work Naitive is doing will potentially help with early diagnosis, meaning measures can be taken before bones are broken and lives are changed. Prevention is a key aim of the NHS and the Royal Osteoporosis Society, and I am pleased to be a representative of lived experience in a project that advances this agenda." 👉 Nic Vine, a Patient Volunteer, commented, "The use of technology to prevent ill health is crucial to the future of the NHS; I am pleased to represent the patient viewpoint in the work on identifying osteoporosis and fracture risk, as a patient advocate with Naitive Technologies and the Royal Osteoporosis Society." Patient feedback is essential to our development process, ensuring that technology like OsteoSight™ has patient benefit at its core. To begin with, the steering committee has been helping us expand OsteoSight™ to detect signals of low bone mineral density from chest and spine X-rays as part of our recently announced @Innovate UK-funded project. "We want to ensure that all decisions are made with the patient's best interest at heart," says Robert Fletcher, Project Lead at Naitive. #HealthcareInnovation #Osteoporosis #AI

Full episode now available on YouTube, Spotify and Apple Podcasts! #gastroenterology #endoscopy #advancedendoscopy #medicaldevices #medtech #healthtech #healthcareinnovation #privateequity #venturecapital #investors #israelinnovation #israelitech #startups

Embracing new technologies in #cardiovascularultrasound not only enhances diagnostic precision but also revolutionizes #patientcare, paving the way for personalized treatment plans and improved outcomes. #AMR #CardiovascularUltrasound #Echocardiography #HealthcareInnovation #AIinMedicine #CloudTechnology #MedicalAdvancements #PatientCare #HealthTech #InnovativeHealthcare #UltrasoundTechnology https://lnkd.in/dd4BgCpP

Still relying on fax machines in 2024? It's time for a leap into the future of healthcare! Check out this eye-opening article by Medscape on why fax machines are still prevalent in oncology practices. Let's embrace digital transformation for faster, more efficient patient care. Read more below: #HealthTech #DigitalHealth #HealthcareInnovation https://lnkd.in/gXZMFb-U

🗞 News of the day #AI to Save Your Eyes Israeli firm AEYE Health's revolutionary AI system offers the potential to save eyesight globally. #Israeli Healthcare Innovation: #Israel stands as a global leader in healthcare innovation, recently gaining FDA approval for an AI system designed to screen for diabetic retinopathy, a condition that affects 27% of diabetics worldwide. AEYE Health's Revolutionary Technology: AEYE Health, based in New York and Tel Aviv, developed AEYE-DS, the first fully autonomous AI system for diabetic retinopathy screening. This technology can be employed at home or in a clinic and has the potential to prevent blindness in diabetic patients if detected early. Global Impact and Future Prospects: AEYE Health's initiative could improve health outcomes for nearly 2.2 billion people suffering from some form of ocular impairment globally. Looking forward, the company, under the leadership of CEO Zack Dvey-Aharon, Ph.D., aims to expand its diagnostic screening capabilities beyond diabetic retinopathy. AEYE Health's groundbreaking technology heralds a new era in eye disease screening, with the potential to save the vision of millions while making healthcare more accessible.

The Healthcare Stage I Episode 7 I Revolutionizing Colonoscopy: Introducing VTM Technologies This episode is dedicated to a conversation with Avishay Sidlesky, The CEO of VTM technologies, an Israeli medical device startup. In the battle against colorectal cancer (CRC), VTM Technologies developed an innovative laser-based Virtual Tape-Measure. This new tool revolutionizes the assessment of polyp size during colonoscopy procedures, offering unparalleled accuracy and objectivity. With FDA approval already secured, VTM Technologies wishes to transform the landscape of CRC screening and surveillance. Colonoscopy, a cornerstone of CRC prevention, holds significant importance in detecting and monitoring the disease, which ranks as the second leading cause of cancer death globally. The accuracy of follow-up colonoscopy guidelines hinges upon precise measurements of polyp size and number. Yet, current methods rely on subjective assessments by gastroenterologists, leaving room for error and potentially dire consequences for patients. The implications of inaccuracies in polyp size assessment are profound. Overestimation may trigger unnecessarily early follow-up colonoscopies, subjecting patients to discomfort and straining healthcare resources. Conversely, underestimation poses a grave risk, delaying cancer diagnosis and compromising survival rates. VTM Technologies' pioneering system addresses these critical challenges head-on. By providing objective measurements, it eliminates the pitfalls of subjective assessment, promising to save lives and reduce healthcare costs. As VTM Technologies embarks on its journey to commercialize the new device, it seeks strategic partnerships and investment to propel its mission forward. This podcast is available on YouTube, Spotify, Apple podcast and the Healthcare Stage LinkedIn page https://lnkd.in/dBDvT7ZN   #TheHealthcareStage #Colonoscopy #coloncancer #VTMtechnologies #Healthcare #Investors #VC #Polyp

More Scanning, Better Imaging, and Effective Simulation = Optimal Aneurysm Treatment!!

More exciting news from Akumin!